Nonpharmacologic and pharmacologic alteration of high-density lipoprotein cholesterol: Therapeutic approaches to prevention of atherosclerosis
- 30 November 1985
- journal article
- Published by Elsevier in American Heart Journal
- Vol. 110 (5) , 1107-1115
- https://doi.org/10.1016/0002-8703(85)90225-x
Abstract
No abstract availableKeywords
This publication has 86 references indexed in Scilit:
- Lipoproteins and lipoprotein metabolismJournal of Molecular Medicine, 1983
- Prostacyclin modulates cholesteryl ester hydrolytic activity by its effect on cyclic adenosine monophosphate in rabbit aortic smooth muscle cells.Journal of Clinical Investigation, 1982
- High density and low density lipoprotein subfractions in survivors of myocardial infarction and in control subjectsMetabolism, 1982
- Relation of angiographically defined coronary artery disease to plasma lipoprotein subfractions and apolipoproteins.BMJ, 1981
- Interconversion of high density lipoproteins during incubation of human plasmaBiochemical and Biophysical Research Communications, 1981
- High-Density Lipoprotein MetabolismPublished by Elsevier ,1980
- High density lipoprotein as a protective factor against coronary heart diseaseThe American Journal of Medicine, 1977
- THE TROMSØHEART-STUDYThe Lancet, 1977
- A MECHANISM BY WHICH HIGH-DENSITY LIPOPROTEINS MAY SLOW THE ATHEROGENIC PROCESSThe Lancet, 1976
- PLASMA-HIGH-DENSITY-LIPOPROTEIN CONCENTRATION AND DEVELOPMENT OF ISCHÆMIC HEART-DISEASEThe Lancet, 1975